LILY AVGUSTOVSKIY: Open Payments
NPI 1093122335 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 16 payments from 11 companies in 2025. Trend: 2023 $126 · 2024 $555 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $115 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Calliditas Therapeutics US Inc. | 3 | $70 |
| ANI Pharmaceuticals, Inc. | 2 | $53 |
| Lilly USA, LLC | 1 | $30 |
| Ardelyx, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: Fabhalta, JYNARQUE, TARPEYO, PURIFIED CORTROPHIN GEL, JARDIANCE, IBSRELA, Kerendia, TAVNEOS.
Industry payments across MT — which companies pay providers there.
